CORVUS PHARMACEUTICALS INC's ticker is CRVS and the CUSIP is 221015100. A total of 65 filers reported holding CORVUS PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.87 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $10,072,000 | +5.4% | 2,081,077 | -41.9% | 0.35% | -2.0% |
| Q2 2021 | $9,557,000 | +376.4% | 3,579,377 | +385.3% | 0.36% | +141.2% |
| Q2 2020 | $2,006,000 | +28.9% | 737,612 | 0.0% | 0.15% | -9.2% |
| Q1 2020 | $1,556,000 | -61.2% | 737,612 | 0.0% | 0.16% | -55.0% |
| Q4 2019 | $4,013,000 | +270.2% | 737,612 | +149.7% | 0.36% | +235.2% |
| Q4 2018 | $1,084,000 | -64.0% | 295,420 | -15.9% | 0.11% | -60.3% |
| Q3 2018 | $3,015,000 | -39.0% | 351,401 | -22.0% | 0.27% | -42.3% |
| Q2 2018 | $4,945,000 | -8.7% | 450,400 | -4.1% | 0.47% | -13.3% |
| Q1 2018 | $5,416,000 | -11.2% | 469,700 | -20.2% | 0.54% | -20.8% |
| Q4 2017 | $6,096,000 | -57.9% | 588,432 | -35.2% | 0.69% | -64.5% |
| Q3 2017 | $14,482,000 | +48.7% | 908,525 | +12.9% | 1.93% | +11.6% |
| Q2 2017 | $9,741,000 | – | 805,000 | – | 1.73% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ADAMS STREET PARTNERS LLC | 3,275,616 | $28,105,000 | 4.42% |
| Novo Holdings A/S | 4,420,516 | $37,928,000 | 3.01% |
| BVF INC/IL | 1,890,507 | $16,221,000 | 1.42% |
| Orbimed Advisors | 5,967,584 | $51,202,000 | 0.62% |
| COWEN INC. | 588,706 | $5,051,000 | 0.46% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 108,000 | $710,000 | 0.34% |
| SPHERA FUNDS MANAGEMENT LTD. | 321,430 | $2,758,000 | 0.32% |
| EcoR1 Capital, LLC | 351,401 | $3,015,000 | 0.27% |
| Rock Springs Capital Management LP | 575,000 | $4,934,000 | 0.18% |
| Hikari Power Ltd | 32,090 | $275,000 | 0.03% |